InsidersTradesSigma
Track the Ensign Group, INC share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Ensign Group, INC has logged 397 public disclosures. Market capitalisation: €10.7bn. The latest transaction was disclosed on 13 August 2026 (Don). Among the most active insiders: SMITH BARRY M. The full history is accessible without an account.
397
Insider Decl.
n/a
Thresholds
€16
1 ops.
Buy Volume
€8m
67 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ensign Group, INC Buy (bullish), based on 5 analysts. Average price target: US$220.00.
29Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,537 of 29,056 companies
45.7
score / 100
Value45
Quality46
FCF yld3.7%
Earn yld3.4%
EV/EBITDA21.6x
ROE17%
Gross mgn16%
Net mgn6.8%
Debt/EBITDA3.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 August 2026
Declarations397 total
2,500 shares0Common StockSEC:0001778500-26-000010:0
175 shares@ US$181.880.0003% mcap6.0% of flowCommon StockSEC:0001764784-26-000010:0
200 shares@ US$185.000.0003% mcap7.0% of flowCommon StockSEC:0001764784-26-000010:1
375 shares@ US$183.5440.0007% mcap14.9% of flowCommonSEC144:0001959173-26-005370
392 shares@ US$171.060.0007% mcap22.4% of flowCommon StockSEC:0001627893-26-000012:0
392 shares@ US$171.060.0007% mcap28.8% of flowCommonSEC144:0001959173-26-005274
600 shares0Common StockSEC:0001764784-26-000008:0
600 shares0Common StockSEC:0001548135-26-000008:0
100 shares@ US$168.120.0002% mcap23.4% of flowCommon StockSEC:0002045482-26-000008:1
600 shares0Common StockSEC:0001741453-26-000006:0
600 shares0Common StockSEC:0001627893-26-000010:0
600 shares0Common StockSEC:0001212067-26-000020:0
600 shares0Common StockSEC:0002045482-26-000008:0
100 shares@ US$168.120.0002% mcap30.5% of flowCommonSEC144:0001959173-26-005239
700 shares@ US$164.280.0010% mcap18.5% of flowCommon StockSEC:0001212067-26-000016:0
700 shares@ US$164.280.0011% mcap5.5% of flowCommonSEC144:0001959173-26-004240
281 shares@ US$172.420.0004% mcap0.8% of flowCommon StockSEC:0001778500-26-000008:0
264 shares@ US$171.970.0004% mcap0.7% of flowCommon StockSEC:0001778500-26-000008:1
509 shares@ US$172.420.0007% mcap1.0% of flowCommon StockSEC:0001417552-26-000008:0
509 shares@ US$171.970.0007% mcap1.0% of flowCommon StockSEC:0001417552-26-000008:1
458 shares@ US$172.420.0007% mcap0.9% of flowCommon StockSEC:0001470396-26-000012:0
458 shares@ US$171.970.0007% mcap0.9% of flowCommon StockSEC:0001470396-26-000012:1
123 shares@ US$172.420.0002% mcap3.7% of flowCommon StockSEC:0001475842-26-000008:0
102 shares@ US$171.970.0001% mcap3.0% of flowCommon StockSEC:0001475842-26-000008:1
326 shares@ US$172.420.0005% mcap1.1% of flowCommon StockSEC:0001609878-26-000008:0
25 of 397 declarations
关于 Ensign Group, INC
Ensign Group, Inc.（股票代码：ENSG）是一家在美国纳斯达克市场上市的美国公司。它在急性后期和长期护理领域运营，其商业模式以医疗保健相关物业和设施（主要是专业护理设施和老年生活社区）的运营、开发、收购和所有权为中心。该公司的概况更接近于一家综合医疗保健运营商和专业房地产投资者，而非传统的医院连锁店。Ensign成立于1999年，通过有纪律的收购、地方运营自主权以及对复杂医疗保健资产的持续再投资，不断发展壮大。（[investor.ensigngroup.net](https://investor.ensigngroup.net/files/doc_financials/2023/q4/2a726b98-24c0-4df7-a4fa-0faa0f9f6a7c.pdf?utm_source=openai)) 该公司总部位于美国加利福尼亚州圣胡安卡皮斯特拉诺。其业务遍及美国多个州，在加利福尼亚州、亚利桑那州以及阳光地带和中西部其他市场拥有重要的历史影响力。公司近期披露的信息显示，其业务遍及17个州，并且其投资组合在2025年和2026年持续扩张。（[investor.ensigngroup.net](https://investor.ensigngroup.net/news/news-details/2025/The-Ensign-Group-Reports-Fiscal-Year-and-Fourth-Quarter-2024-Results-Issues-2025-Earnings-Guidance/default.aspx?utm_source=openai)) 在运营方面，Ensign提供广泛的急性后期医疗保健服务，包括专业护理、老年生活、物理治疗、职业治疗、言语治疗以及其他以康复为导向的医疗保健服务。该公司还拥有重要的房地产组成部分，收购或租赁支持运营所需的物业。这种混合模式具有战略重要性：它使Ensign能够获得运营现金流和医疗保健房地产经济效益，同时还支持灵活的资本配置框架。与更传统的医疗保健提供商相比，这种结构在整合机会仍然存在的碎片化市场中可能是一个优势。（[investor.ensigngroup.net](https://investor.ensigngroup.net/files/doc_financials/2024/q1/c07fd213-2753-4135-9e7e-935b1d634569.pdf?utm_source=openai)) 在竞争方面，Ensign以其分散的管理文化、地方运营重点以及整合新设施的持续能力而脱颖而出。2024年和2025年全年业绩显示出持续的增长势头，管理层在年内多次上调年度指引。在2026年第一季度，该公司再次上调了全年展望，理由是强劲的运营业绩和近期收购。Ensign还在2025年提高了季度股息，突显了增长和资本回报纪律的结合。（[investor.ensigngroup.net](https://investor.ensigngroup.net/news/news-details/2025/The-Ensign-Group-Reports-Fiscal-Year-and-Fourth-Quarter-2024-Results-Issues-2025-Earnings-Guidance/default.aspx?utm_source=openai)) 对于法语投资者而言，ENSG是一家专业的美国医疗保健复合型公司，与结构性老龄化趋势、对康复服务的持续需求以及专业护理和老年生活行业的长期整合相关。需要关注的关键驱动因素仍然是收购主导的增长、运营利润执行、入住率和报销趋势，以及公司在不稀释回报的情况下持续整合新站点的能力。近期在多个州的收购证实，Ensign在美国国内市场仍然活跃且具有机会主义。（[investor.ensigngroup.net](https://investor.ensigngroup.net/news/news-details/2025/The-Ensign-Group-Increases-Operations-in-Arizona/default.aspx?utm_source=openai))
